Search for Clinical Trial Results
Granuloma - 203 Studies Found
Status | Study |
Terminated |
Study Name: CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors Condition: Churg-Strauss Syndrome Date: 2006-11-13 Interventions:
|
Completed |
Study Name: Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome Condition: Churg Strauss Syndrome Date: 2008-07-14 Interventions: Drug: mepolizumab 750 mg mepolizumab iv q4wk until week 32 |
Not yet recruiting |
Study Name: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome Condition: Churg-Strauss Syndrome Date: 2016-03-14 Interventions: Biological: HPC cell infusion Administration of total lymp |
Not yet recruiting |
Study Name: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study Condition: Asthma Date: 2016-10-17 Interventions: Drug: Reslizumab All subjects will receive Reslizumab |
Completed |
Study Name: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) Condition:
|
Recruiting |
Study Name: Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study Condition: Asthma Date: 2016-12-11 Interventions: Drug: Benralizumab one injection 30 mg under the subjects skin every 4 weeks for 8 weeks and then every |
Recruiting |
Study Name: PRO Development for ANCA Associated Vasculitis Condition:
|
Completed |
Study Name: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides Condition:
Interventions: |
Completed |
Study Name: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides Condition:
Interventions: |
Completed |
Study Name: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Condition:
|